Drug Repurposing for Cancer Treatment: A Comprehensive Review
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Abdulaziz H Al Khzem und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Eastern Pr…. Hauptthemen laut MEDLINE: Drug Repositioning, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer ranks among the primary contributors to global mortality. In 2022, the global incidence of new cancer cases reached about 20 million, while the number of cancer-related fatalities reached 9.7 million. In Saudi Arabia, there were 13,399 deaths caused by cancer and 28,113 newly diagnosed cases of cancer. Drug repurposing is a drug discovery strategy that has gained special attention and implementation to enhance the process of drug development due to its time- and money-saving effect. It involves repositioning existing medications to new clinical applications. Cancer treatment is a therapeutic area where drug repurposing has shown the most prominent impact. This review presents a compilation of medications that have been repurposed for the treatment of various types of cancers. It describes the initial therapeutic and pharmacological classes of the repurposed drugs and their new applications and mechanisms of action in cancer treatment. The review reports on drugs from various pharmacological classes that have been successfully repurposed for cancer treatment, including approved ones and those in clinical trials and preclinical development. It stratifies drugs based on their anticancer repurpose as multi-type, type-specific, and mechanism-directed, and according to their pharmacological classes. The review also reflects on the future potential that drug repurposing has in the clinical development of novel anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Eastern Province, Saudi Arabia.
- College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Eastern Province, Saudi Arabia.
ORCID-Profile: Abdulaziz H Al Khzem, Mohamed S Gomaa, Mansour S Alturki, Nada Tawfeeq, Mohammad Sarafroz
Zitieren
APA
Al Khzem, A. H., Gomaa, M. S., Alturki, M. S., Tawfeeq, N., Sarafroz, M., Alonaizi, S. M., Al Faran, A., Alrumaihi, L. A., Alansari, F. A., & Alghamdi, A. A. (2024). Drug Repurposing for Cancer Treatment: A Comprehensive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212441
Vancouver
Al Khzem AH, Gomaa MS, Alturki MS, Tawfeeq N, Sarafroz M, Alonaizi SM, et al. Drug Repurposing for Cancer Treatment: A Comprehensive Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212441
BibTeX
@article{AlKhzem2024,
author = {Al Khzem, Abdulaziz H and Gomaa, Mohamed S and Alturki, Mansour S and Tawfeeq, Nada and Sarafroz, Mohammad and Alonaizi, Shareefa M and Al Faran, Alhassan and Alrumaihi, Laela Ahmed and Alansari, Fatimah Ahmed and Alghamdi, Abdullah Abbas},
title = {Drug Repurposing for Cancer Treatment: A Comprehensive Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212441}
}
EUVIMED